Chronic and repeated Chlamydophila pneumoniae lung infection can result in increasing IL-4 gene expression and thickness of airway subepithelial basement membrane in mice

Journal of the Formosan Medical Association

Volumn 108, Issue 1, 2009, Pages 45-52

  Chen, Chiung Zuei ^a   Yang, Bei Chang ^b   Lin, Tsun Mei ^b   Lee, Cheng Hung ^a   Hsiue, Tzuen Ren ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Airway remodeling; Chlamydophila pneumoniae; Interleukin 4

Indexed keywords

BETA ACTIN; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BASEMENT MEMBRANE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION; HISTOPATHOLOGY; INOCULATION; LUNG INFECTION; LUNG LAVAGE; MORPHOMETRICS; MOUSE; NONHUMAN; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THICKNESS;

EID: 60149109947     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60031-0     Document Type: Article

References (30)

1. Hammerschlag MR. Chlamydia pneumoniae and the lung. Eur Respir J 2000;16:1001-7.
2. Branden E, Koyi H, Gnarpe J, et al. Chronic Chlamydia pneumoniae infection is a risk factor for the development of COPD. Respir Med 2005;99:20-6.
3. Martin RJ, Kraft M, Chu HW, et al. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001; 107:595-601.
4. Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae strain TWAR infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 1991;266:225-30.
5. Von Hertzen LC. Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumonia. Eur Respir J 2002;19:546-56.
6. Hahn DL, McDonald R. Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma. Ann Allergy Asthma Immunol 1998;81:339-44.
7. Gencay M, Rudiger JJ, Tamm M, et al. Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma. Am J Respir Crit Care Med 2001;163:1097-100.
8. Leigh R, Ellis R, Wattie JN, et al. Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice. Am J Respir Crit Care Med 2004;169: 860-7.
9. Temann UA, Prasad B, Gallup MW, et al. A novel role for murine IL-4 in vivo: induction of MUC5AC gene expression and mucin hypersecretion. Am J Respir Cell Mol Biol 1997;16:471-8.
10. Trautmann A, Krohne G, Brocker EB, et al. Human mast cells augment fibroblast proliferation by heterotypic cell-cell adhesion and action oh IL-4. J Immunol 1998;160:5053-7.
11. Postlethwaite AE, Holness MA, Katai H, et al. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin-4. J Clin Invest 1992;90:147-9.
12. Penttila J, Anttila M, Paolakkainen M, et al. Local immune response to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection. Infect Immun 1998;66:5113-8.
13. Halme S, Latvala J, Karttunen R, et al. Cell-mediated immune response during primary Chlamydia pneumonia infection. Infect Immun 2000;68:7156-8.
14. Curfs JH, Meis JF, Hoogkamp-Korstanje JA, et al. A primer on cytokines sources, receptors, effects, and inducers. Clin Microbiol Rev 1997;10:742-80.
15. Burian K, Hegyesi H, Buzas E, et al. Chlamydophila pneumonia induces histidine decarboxylase production in the mouse lung. Immunol Lett 2003;89:229-36.
16. Coyle AJ, Le Gros G, Bertrand C, et al. Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am J Respir Cell Mol Biol 1995;13:54-9.
17. Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin-13: central mediator of allergic asthma. Science 1998;282: 2258-61.
18. Humbert M, Durham SR, Ying S, et al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against intrinsic asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med 1996;154:1497-504.
19. Kuo CC. Pathological manifestation of Chlamydia infection. Am Heart J 1999;138:S496-9.
20. Laitinen K, Alakarppa H, Laurila A, et al. Animal models for Chlamydia pneumoniae infection. Scand J Infect Dis 1997;104:S15-7.
21. Yang ZP, Kuo CC, Grayston JT. A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis. Infect Immun 1993; 61:2037-40.
22. Kaukoranta-Tolvanen SS, Laurila A, Saikku P, et al. Experimental Chlamydia pneumaniae infection in mice: effect of reinfection and passive immunization. Microb Pathog 1995; 18:279-88.
23. McMillan SJ, Lloyd CM. Prolonged allergen challenge in mice leads to persistent airway remodeling. Clin Exp Allergy 2004;34:497-507.
24. Halme S, Saikku P, Surcel HM. Characterization of Chlamydia pneumoniae antigens using human T cell clones. Scand J Immunol 1997;45:378-84.
25. Kaukoranta-Tolvanen SS, Teppo AM, Laitinen K, et al. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb Pathog 1996;21:215-21.
26. Von Hertzen LC. Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae. Eur Respir J 2002;19:546-56.
27. Redecke V, Dalhoff K, Bohnet S, et al. Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response. Am J Respir Cell Mol Biol 1998;19:721-7.
28. Svanholm C, Bandholtz L, Castanos-Velez E, et al. Protective DNA immunization against Chlamydia pneumoniae. Scand J Immunol 2000;51:345-53.
29. Dlugovitzky D, Bay ML, Rateni L, et al. In vitro synthesis of interferon, interleukin-4, transforming growth factor-β and interleukin-1β by peripheral blood mononuclear cells from tuberculosis patients: relationship with the severity of pulmonary involvement. Scand J Immunol 1999;49: 210-7.
30. Fahy JV. Remodeling of airway epithelium in asthma. Am J Respir Crit Care Med 2001;164:S46-51.